agenda
Day 1: 21 September 2020
| 9:00 (CET) |
| Coronaviruses: History and Biology Prof. Susan R. Weiss Penn Center for Research on Coronaviruses & Emerging Pathogens, University of Pennsylvania, USA |
| 10:00 |
| Spatiotemporal analysis of micro-epidemics of influenza and COVID-19 Prof. Eleftherios Mylonakis Alpert Medical School of Brown University, Rhode Island Hospital & The Miriam Hospital, USA |
| 11:00 |
| Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection Prof. Craig B. Wilen Yale School of Medicine Departments of Laboratory Medicine & Immunobiology, New Haven, USA |
| 13:00 |
| SARS-CoV-2 mechanisms of severe outcomes Dr Jeremy W Prokop Department of Pharmacology & Toxicology, Michigan State University, Grand Rapids, USA |
| 14:00 |
| Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications Dr Corrado Pelaia University “Magna Græcia” of Catanzaro, Italy |
| 15:00 |
| A new potential therapy for COVID-19 based on anti-JAK inhibitors: clinical studies and analysis of the mechanisms of action Dr Delia Goletti National Institute for Infectious Disease L. Spallanzani, Rome, Italy |
| 16:00 |
| Laboratory Biosafety in the Time of COVID-19 Dr Michael Baclig St. Luke’s Medical Center |
| 17:00 |
| Allosteric site of SARS-CoV-2 main protease as drug target in the presence of its emerging mutations Prof. A. Ozlem Tastan Bishop Department of Biochemistry and Microbiology, Rhodes University, South Africa |
| 17:30 |
| COVID 19 Risk factors and therapies in Italy: results from the CORIST collaboration Prof. Licia Iacoviello IRCCS Neuromed, Pozzilli & University of Insubria Varese, Italy |
| 17:45 |
| Poster Talk: Obstacles to mental health screening in hospitalized COVID-19 patients Erin Reed Yale School of Medicine New Haven, USA |
Day 2: 22 September 2020
| 9:00 (CET) |
| Optimally Pooled COVID-19 Testing Prof. Dor Ben-Amotz Purdue University, Department of Chemistry West Lafayette, IN, USA |
| 10:00 |
| Contolling the second Covid-19 wave by Mandatory Mobile Contact Tracing (MMCT) Containment and Time Dependent Doubling Time Control Prof. Antonio Bianconi Rome International Center for Materials Science, Superstripes, Roma, Italy |
| 11:00 |
| Lessons learned from animal models of COVID-19 Prof. Ravi Mahalingam University of Colorado Anschutz Medical Campus, USA |
| 13:00 |
| Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19 Prof. Dr. Manuela Teresa Raimondi Politecnico di Milano, Milano, Italy |
| 14:00 |
| Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies Dr Hanalise V Huff Boston Children’s Hospital, Harvard Medical School, USA |
| 15:00 |
| Stem cells from gestational tissues: a promising tool to restore the body’s own potential to fight SARS-CoV-2 infections Dr Bruna Corradetti Houston Methodist Research Institute, USA |
| 16:00 |
| Allelic Variations in ACE2 and Natural Resistance against COVID-19 Dr Mushtaq Hussain Dow University of Health Sciences, Karachi, Pakistan |
| 17:00 |
| Innovative Therapeutic Interventions for SARS-CoV-2 – exploiting metabolic synergy Prof. Rushika Perera Arthropod-borne & Infectious Diseases Laboratory Colorado State University, USA |
| 17:30 |
| Poster Talk: SARS-CoV-2 diagnostic markers – Missing clues to the bigger picture Sundararaj Stanleyraj Jeremiah Yokohama City University, Fukuura, Japan |
Day 3: 23 September 2020
| 9:00 (CET) |
| Internet Knowledge Mining tools and A.I. For Rapid Response to New Pandemics with Proposals for Synthetic Vaccines and Therapeutics. The Example of COVID19 Prof. Dr Barry Robson Ingine Inc. Cleveland Ohio, USA |
| 10:00 |
| Epidemiological monitoring and comparative analysis of non-pharmaceutical interventions using a non-Markovian modelling framework Prof. Mircea T. Sofonea University of Montpellier, France |
| 11:00 |
| Molecular basis of COVID-19 comorbidities Prof. Antonio Facchiano Istituto Dermopatico dell’Immacolata (IDI-IRCCS), Rome, Italy |
| 13:00 |
| Screening Possible Drug Molecules for Covid-19: A Computational Study based on Docking Studies & Molecular Dynamics to Design New Inhibitor Candidates Dr. Manos Vlasiou department of Health and Life Sciences, University of Nicosia, Nicosia, Cyprus |
| 14:00 |
| Gut-lung axis in COVID-19 Dr Busra Aktas Burdur Mehmet Akif Ersoy University, Burdur, Turkey |
| 16:00 |
| Generation of SARS-CoV-2 S1 spike glycoprotein putative antigenic epitopes in vitro by intracellular aminopeptidases Dr Efstratios Stratikos National Center for Scientific Research Demokritos, Greece |
| 17:00 |
| Covid-19, The King of 2020: lessons learned and still learning from a tertiary care centre in Chennai, India Prof. Padma Srikanth Dept of Microbiology, Sri Ramachandra Institute, India |
| 17:30 |
| Poster Talk: Explainable approach for COVID-19 identification via CT-Scans Eduardo Almeida Soares Lancaster University, UK |
Day 4: 24 September 2020
| 9:00 (CET) |
| Vesicular stomatitis virus vectored vaccine for SARS-CoV-2 Prof. Sean P. J. Whelan Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, USA |
| 10:00 |
| Potential connections of COVID-19 and prostate cancer – the TMPRSS2 story Prof. Jianyu Rao UCLA Medical Center, Santa Monica, LA, USA |
| 11:00 |
| Pulse Therapy with Corticosteroids and Intravenous Immunoglobulin in the Management of Severe COVID-19. Unusual Treatment with Intriguing Results Prof. Mikhail Sheianov Burnasyan Federal Medical Biophysical Center, Moscow, Russia |
| 13:00 |
| Targeting the Master Regulator of Cellular Redox Homeostasis, Nrf2, in SARS-CoV-2 Infection Prof. Adela Cota-Gomez Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, USA |
| 14:00 |
| Complement and neutrophil-mediated immunothrombosis: lessons from COVID-19 Prof. Panagiotis Skendros Democritus University of Thrace (DUTH), University Hospital of Alexandroupolis, Greece |
| 15:00 |
| EARLY PREDICTION OF COVID-19 IN CUBA USING THE SEIR MODEL Prof. Dr Luis Beltrán Ramos-Sánchez University of Camagüey, Camagüey. Cuba |
| 16:00 |
| How Molecular Modelling Could help in the COVID19 Crisis Dr. Muhamed Amin University of Groningen, Groningen, Netherlands |
| 17:00 |
| Weighing the Impact of Obesity on COVID-19 in Low- to Middle-Income Countries Dr Dicky L. Tahapary Faculty of Medicine Universitas Indonesia (RSCM-FKUI), Indonesia |
| 17:30 |
| Poster Talk: The use of Computational Docking to estimate the effects of Montelukast on potential viral main protease catalytic site Dr Salman Mansoor Sligo University Hospital, Ireland |
Day 5: 25 September 2020
| 9:00 (CET) |
| Developing a Point-of-Risk Molecular Test for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dr Laura Lamb Oakland University William Beaumont School of Medicine, Rochester Hills, Michigan, USA |
| 10:00 |
| In silico drug discovery for COVID-19 using gene expression profiles of mouse infected by MHV and those of human cell lines infected by SARS-CoV-2 Prof. Y-h. Taguchi Department of Physics, Chuo University, Tokyo, Japan |
| 11:00 |
| SARS-CoV-2 Associated Nephropathy in the Pandemic Era Prof. Maurizio Salvadori Department of Nephrology and Transplantation, University of Florence, Florence, Italy |
| 13:00 |
| Machine learning analysis of single-cell gene regulatory networks reveals potential mechanisms of action of antimalarials against SARS-CoV-2 Prof. James Cai Texas A&M University, USA |
| 14:00 |
| COVID-19 pathophysiology may be driven by a loss of inhibition of the Renin-Angiotensin-Aldosterone System Dr Johan Lundberg Karolinska University Hospital, Stockholm, Sweden |
| 15:00 |
| The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections Dr Tibor Bakács Hungarian Academy of Sciences & HepC Inc, Hungary |
| 16:00 |
| Vaccine and Drug Designing for COVID-19- Research and Prevention Strategies Dr Syed Sikander Azam Quaid-i-Azam University, Islamabad, Pakistan |
| 17:00 |
| The higher the altitude the less COVID-19: Decreased incidence, transmission capacity of the virus and severity at altitude in the American continent Christian Arias Reyes Faculty of Medicine, Université Laval, Québec, QC, Canada |
| 17:30 |
| Poster Talk: Homologous Proteins in Drosophila melanogaster for SARS-CoV-2/Human Interactome Sanya Shabbir Dow University of Health Sciences, Karachi, Pakistan |
| 17:45 |
| Poster Talk: Filipino next generation nurses as frontliners amid COVID-19 pandemic: A Husserlian phenomenology study Dr Agnes Valencia-Raymundo Manila central University College of nursing, Caloocan City, Philippines |
★ Agenda is being updated regularly
